Compounding Pharmacy Recalls Anti-Inflammatory Drug in 13 States
Main Street Family Pharmacy LLC has announced a voluntary recall of one of its pharmaceutical products. The product, an injectable anti-inflammatory drug, has been linked to seven cases of adverse events in the form of skin abscesses, one of which, the FDA reports, appears to be fungal in nature. Although the investigation into the exact source of the adverse events is still ongoing, the FDA and Main Street are not taking any chances. “The company is fully supportive and complaint with the FDA’s recommendation that a voluntary recall take place and patients not be administered this compound medicine until the investigation is complete,” Main Street Family Pharmacy said in an official statement.
Main Street, which is based out of Newbern, Tennessee, is a compounding pharmacy that mixes drugs to create custom products pursuant to a doctor’s specifications. Last year, the use of such drugs was linked to a deadly outbreak of fungal meningitis, leading the FDA to increase its efforts to inspect and regulate compounding pharmacies. As a result, there have been a number of national recalls of potentially contaminated drugs.
Due to the increasing size and prevalence of compounding pharmacies across the country, Congress has introduced legislation that would give the FDA direct oversight over these companies. The bill has yet to pass, but the hope would be to help prevent future outbreaks of diseases associated with the use of compound medications.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.